Collectively from all these reports, we illustrate sequential events upon nc886 silencing during ESCC carcinogenesis as follows: AKT activation, FOXO and E2F suppression, down-regulation of CDK inhibitors, promotion of the G1-S transition, and eventually fast cell proliferation (Figure 8). The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.